XML 32 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity
6 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Stockholders' Equity

Note 11. Stockholders’ Equity

On October 2, 2019, we registered the issuance of 6,350,000 shares of Common Stock, par value $0.01 per share (“Common Stock”), consisting of 5,300,000 shares of Common Stock reserved for issuance upon the exercise of options granted, or in respect of awards granted, under the Cerence 2019 Equity Incentive Plan (“Equity Incentive Plan”), and 1,050,000 shares of Common Stock that are reserved for issuance under the Cerence 2019 Employee Stock Purchase Plan. The Equity Incentive Plan provides for the grant of incentive stock options, stock awards, stock units, stock appreciation rights, and certain other stock-based awards. The shares available for issuance will automatically increase on January 1st of each year, by the lesser of (A) 3% of the number of shares of Common Stock outstanding as of the close of business on the immediately preceding December 31st; and (B) the number of shares of Common Stock determined by the Board on or prior to such date for such year. On March 4, 2024, we registered the issuance of 600,000 shares of Common Stock, reserved for issuance under the Cerence Inc. 2024 Inducement Plan.

 

Restricted Units

 

Information with respect to our non-vested restricted stock units for the six months ended March 31, 2024 was as follows:

 

 

Non-Vested Restricted Stock Units

 

 

Time-Based
Shares

 

Performance-
Based Shares

 

Total Shares

 

Weighted-
Average
Grant-Date
Fair Value

 

Weighted-
Average
Remaining
Contractual
Term (years)

 

Aggregate
Intrinsic
Value
(in thousands)

 

Non-vested at September 30, 2023

 

2,372,145

 

 

1,145,550

 

 

3,517,695

 

$

32.52

 

 

 

 

 

Granted

 

2,084,023

 

 

406,166

 

 

2,490,189

 

$

17.37

 

 

 

 

 

Vested

 

(1,232,235

)

 

(63,998

)

 

(1,296,233

)

$

35.06

 

 

 

 

 

Forfeited

 

(122,308

)

 

(137,068

)

 

(259,376

)

$

39.93

 

 

 

 

 

Non-vested at March 31, 2024

 

3,101,625

 

 

1,350,650

 

 

4,452,275

 

$

23.63

 

 

 

 

 

Expected to vest

 

 

 

 

 

4,452,275

 

$

23.63

 

 

1.34

 

$

70,079

 

 

Stock-based Compensation

 

Stock-based compensation was included in the following captions in our Condensed Consolidated Statements of Operations for the three and six months ended March 31, 2024 and 2023 (in thousands):

 

 

 

Three Months Ended March 31,

 

 

Six Months Ended March 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Cost of connected services

 

$

64

 

 

$

175

 

 

$

145

 

 

$

371

 

Cost of professional services

 

 

601

 

 

 

1,012

 

 

 

1,161

 

 

 

2,165

 

Research and development

 

 

2,548

 

 

 

4,088

 

 

 

6,379

 

 

 

8,542

 

Sales and marketing

 

 

372

 

 

 

1,522

 

 

 

1,090

 

 

 

3,182

 

General and administrative

 

 

1,160

 

 

 

5,558

 

 

 

4,350

 

 

 

10,567

 

 

$

4,745

 

 

$

12,355

 

 

$

13,125

 

 

$

24,827